Identification of PSMD2 as a promising biomarker for pancreatic cancer patients based on comprehensive bioinformatics and in vitro studies

Identification of PSMD2 as a promising biomarker for pancreatic cancer patients based on comprehensive bioinformatics and in vitro studies

Background: Pancreatic cancer patients have limited treatment options and extremely poor prognosis. Dysregulations of proteasome 26S subunit, non-ATPases (PSMDs) contribute to the development of various cancers, whereas the significance of PSMDs in pancreatic cancer is poorly understood. In the pres...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiuxue Feng, Qiang Liu, Huikai Li, Jing Yang, Enqiang Linghu
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:Heliyon
Subjects:
Pancreatic cancer
PSMDs
PSMD2
PSMD14
AKT/mTOR
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024161488
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items